Skip to main content
OpenTrials

Clinical trial condition

Pantothenate Kinase-Associated Neurodegeneration

Explore clinical trials studying Pantothenate Kinase-Associated Neurodegeneration. Study availability and eligibility vary by location and protocol.

7 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Pantothenate Kinase-Associated Neurodegeneration trial results

Recruiting

TIRCON International NBIA Registry

NCT05522374

Conditions
Aceruloplasminemia, Basal Ganglia Diseases, Beta-Propeller Protein-Associated Neurodegeneration (BPAN), +23 more
Locations
  • Children's Hospital of Eastern Ontario, Division of Neurology, Department of Pediatrics Ottawa, Canada
  • Charles University, Department of neurology Prague, Czechia
  • LMU Klinikum, Friedrich-Baur-Institute Munich, Bavaria, Germany
  • The Foundation of the Carlo Besta Neurological Institute, IRCCS Milan, Italy
View Trial Details
Completed

Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration

NCT02174848

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +8 more
Locations
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Klinikum der Universität München Munich, Germany
  • Foundation Neurological Institute C. Besta Milan, Italy
  • Newcastle University Institute of Human Genetics Newcastle upon Tyne, United Kingdom
View Trial Details
Completed

Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)

NCT01741532

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +8 more
Locations
  • Children's Hospital & Research Center at Oakland Oakland, California, United States
  • Klinikum der Universität München Munich, Germany
  • Foundation Neurological Institute C. Besta Milan, Italy
  • Newcastle University Institute of Human Genetics Newcastle upon Tyne, United Kingdom
View Trial Details

Related conditions